Paul Revill

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: a cost-effectiveness modelling analysis”.

Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: a cost-effectiveness modelling analysis

The Lancet HIV(2025)10.1016/s2352-3018(25)00169-9

N/A

0.104DataRank · unranked

1 citations

Matthew D. Hickey, Starley B. Shade, Jane Kabami, James Ayieko, Paul Revill +10 more

Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub‐Saharan African settings: a cost‐effectiveness analysis

Journal of the International AIDS Society(2021)10.1002/jia2.25651

N/A

0DataRank · unranked

10 citations

Aditya R Gandhi, Martina Penazzato, Djøra I. Soeteman, Paul Revill, Simone C. Frank +14 more

Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models

The Lancet Global Health(2022)10.1016/s2214-109x(22)00310-2

N/A

0DataRank · unranked

28 citations

Lise Jamieson, Hae‐Young Kim, Ingrida Platais, Masabho Milali, Edinah Mudimu +10 more

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

The Lancet Global Health(2021)10.1016/s2214-109x(21)00025-5

N/A

0DataRank · unranked

75 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Peter Ehrenkranz, Celicia Serenata, François Venter +6 more

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV(2023)10.1016/s2352-3018(22)00365-4

N/A

0DataRank · unranked

64 citations

Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver +32 more

Population health impact, cost-effectiveness, and affordability of community-based HIV treatment and monitoring in South Africa: A health economics modelling study

PLOS Global Public Health(2023)10.1371/journal.pgph.0000610

N/A

0DataRank · unranked

6 citations

Cara J. Bayer, D. Allen Roberts, Heidi van Rooyen, Alastair van Heerden, Maryam Shahmanesh +12 more

Perspectives on the use of modelling and economic analysis to guide HIV programmes in sub-Saharan Africa

The Lancet HIV(2022)10.1016/s2352-3018(22)00035-2

N/A

0DataRank · unranked

7 citations

Ajay Rangaraj, Albert Makochekanwa, Amon Mpofu, Andrea L. Ciaranello, Andreas Jahn +46 more